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Cooperative effectsIn this study, an amphibian antimicrobial peptide, aurein 2.3,was predicted to use oblique orientatedα-helix forma-
tion in its mechanism of membrane destabilisation. Molecular dynamic (MD) simulations and circular dichroism
(CD) experimental data suggested that aurein 2.3 exists in solution as unstructured monomers and folds to form
predominantly α-helical structures in the presence of a dimyristoylphosphatidylcholine membrane. MD showed
that the peptide was highly surface active, which supported monolayer data where the peptide induced surface
pressure changes>34 mN m−1. In the presence of a lipid membrane MD simulations suggested that under hydro-
phobicmismatch the peptide is seen to insert via oblique orientationwith a phenylalanine residue (PHE3) playing a
key role in themembrane interaction. There is evidence of snorkelling leucine residues leading to furthermembrane
disruption and supporting the high level of lysis observed using calcein release assays (76%). Simulations performed
at higher peptide/lipid ratio show peptide cooperativity is key to increased efﬁciency leading to pore-formation.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs) are of signiﬁcant interest because
of their potential to eliminate major problems facing medical practice
such as the increasing occurrence of resistance to antimicrobial
agents [1–3]. There have been extensive studies on the antimicrobial
action of AMPs, which have shown that whilst some appear to attack
intracellular targets, in most cases, direct attack on the microbial
membrane itself is the primary killing mechanism [4–6]. Research
has shown that cationic AMPs use different mechanisms of mem-
brane interaction depending on the lipid composition of the target
membrane and the peptide's molecular architecture [7]. The main
mechanisms of cationic AMP interaction involve either pore forma-
tion via the barrel stave, toroidal pore or carpet mechanism [8]. It is
generally assumed that the AMPs involved in membrane interaction
are highly ordered, helical and at least initially, are orientated perpen-
dicular to the plane of the membrane [9]. However, for many AMPs, a
number of studies have predicted that these peptides adopt an
oblique orientation when partitioning into bacterial membranes
[10,11]. Oblique orientated α-helices are protein structural elements
that disrupt membrane lipid organisation via membrane insertion at
an angle between 30° and 60° [9,12,13]. These α-helices have been
described in a wide variety of proteins but very few studies havee; CD, circular dichroism; DMPC,
yl)-1-piperazineethanesulfonic
cular dynamic; NMR, nuclear
, structure–activity relationship;
ations
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ix).
l rights reserved.been undertaken into what may be a highly effective mechanism of
action. Amphibian α-helical antimicrobial peptides (α-AMPs) such
as aurein 1.2 and citropin 1.1 have been shown to destabilise mem-
branes via bilayer penetration at an angle of 50° using nuclear mag-
netic resonance spectroscopy (NMR) and circular dichroism (CD)
[10]. These results show clear parallels to the membrane disruptive
mechanisms utilised by oblique orientatedα-helix forming molecules
such as the viral fusion peptide HA2 [14]. Researchers [10,11,15] have
shown that the adoption of these oblique structures could induce
membrane lysis by the destabilisation of lipid packing [16,17] due
to hydrophobic mismatch. Mismatch occurs when the hydrophobic
stretches of a peptide/protein do not match the thickness of the hy-
drophobic core of the bilayer interior [18], causing the conformations
of the lipids and/or peptides to orientate themselves to minimise ex-
posure of the hydrophobic domains to the aqueous phase. As a result
of these changes, amphiphilic α-helical structures may tilt their heli-
ces, causing shallow penetration of the peptide into the hydrophobic
core of the lipid interior. This leads to the lipid headgroups being
pushed aside by the peptide, thereby forcing a gap to form in the
membrane hydrophobic region causing breakdown of the membrane
[19]. The lipids may also distort their acyl chains by stretching or
compression to match the peptide molecular architecture [20], so
causing changes in membrane thickness.
Structure–activity relationship (SAR) studies on model AMPs have
involved the systematic modiﬁcation of naturally occurring AMPs
such as magainin, to provide templates for the design of de novo
AMPs, with increased antimicrobial activity but decreased toxicity to-
wards host cells [21,22]. In particular, aurein peptides have been used
as part of a SAR study to develop analogues of aurein 1.2 with enhanced
antimicrobial activity [23]. Aurein peptides are naturally found in skin
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They display a wide range of sequence diversity and show activity with
respect to both bacterial and tumour membranes so providing ideal
candidates for the development of lead therapeutic agents [23,24]. In
the present study, aurein 2.3 (GLFDIVKKVVGAIGSL-CONH2) [25] was
used to investigate the role of oblique orientation in the mechanism of
membrane action. Aurein 2.3 is known to have activity against a variety
of prokaryotic and eukaryotic organisms [15] and has been described as
having anti-tumour activity in mammals [26–28]. Here membrane in-
teractions of aurein 2.3 with dimyristoylphosphatidylcholine (DMPC),
the major component of mammalian cells, are extensively studied
using Langmuir monolayers and CD. Furthermore, MD simulations are
used to determine the role played by water in the penetration of the
peptide into the membrane and to study the interactions between the
peptides and the membrane. These simulations provide evidence for
the ﬁrst time, as to how cooperative effects between aurein molecules
can drive deeper membrane penetration by the peptide, so supporting
high levels of efﬁcacy.
2. Materials and methods
2.1. Materials
Aurein 2.3 was synthesised by Severn Biotech to purity greater than
99%. Dimyristoylphosphatidylcholine (DMPC) was supplied by Avanti
Polar Lipids, Inc. All other reagents were supplied by Sigma-Aldrich Ltd.
2.2. CD secondary structure
CD samples with a constant aurein 2.3 peptide concentration of
120 μM were prepared in solution and in peptide:lipid molar ratio of
1:2. DMPC (19 mg ml−1) was dissolved in chloroform and dried
under N2 gas before being vacuum-dried. The lipid ﬁlm was hydrated
in phosphate-buffered saline (PBS) pH 7.5 at a total lipid concentration
of 10 mg ml−1, freeze-thawed 4 times and extruded 11 times with a
0.1 μm polycarbonate ﬁlter using an Avanti Polar Lipids mini-extruder
apparatus. The CD measurements were performed on a Jasco J-815 CD
spectropolarimeter (JASCO UK) with 1 mm quartz cuvettes. Ten scans
per sample were performed at 30 °C using a Peltier temperature con-
troller over a wavelength range 180 to 350 nm, with a 0.2 nm step
resolution and a 100 nm/min scan speed. Samples without peptide
were prepared for background spectral subtraction. The helicity of the
peptides was estimated from the mean residue ellipticity at 222 nm
according to as previously described by Forood et al., [29].
2.3. Surface activity measurement
Surface activity experiments were performed in a 15 cm2 Teﬂon
trough (Biolin Scientiﬁc\KSV NIMA, Coventry, UK) at 21±1 °C
equipped with a Wilhelmy plate. Increasing volumes of 2 mM aurein
2.3 in 10 mM Tris pH 7.5 were injected into a 10 mM Tris pH 7.5
subphase through a sample hole using a Hamilton microsyringe. The
adsorption of aurein 2.3 at the air/water interface was monitored by
increases in surface pressure for 60 min.
2.4. Compression isotherm analysis
Pressure-area isotherms were performed on a Langmuir NIMA
601M ﬁlm balance (Biolin Scientiﬁc\KSV NIMA, Coventry, UK)
equipped with Derlin moveable barriers and a Wilhelmy plate. At
21±1 °C, 1.79×1015 molecules of peptide (in methanol) were
spread onto a 10 mM Tris buffer subphase (pH 7.4). After allowing
30 min for stabilisation, the monolayer was compressed at a rate of
0.27 nm2 min−1. The ﬁlm was compressed until collapse pressure
had been observed. Each run was repeated 6 times.The phase state of the isothermwas then characterised using com-
pressional moduli (Eq. 1) according to Li et al., [30].
C−1s ¼−A
δπ
δA
 
ð1Þ
where (π) represents monolayer surface pressure and (A) is the area
per molecule in the monolayer.
2.5. Peptide penetration measurement
Penetration of aurein 2.3 into lipid ﬁlms was measured using a
Teﬂon trough (subphase volume 15 ml) at ambient temperature
(~21 °C). Surface pressure (π) was measured using a Wilhelmy wire
attached to a microbalance (Biolin Scientiﬁc\KSV NIMA, Coventry,
UK). DMPC (1 mg ml−1) in chloroform was spread onto a 10 mM
Tris pH 7.5 buffer subphase. The lipid monolayers were allowed to
equilibrate for 15 min at an initial π of 30 mN m−1 before injecting
aurein 2.3 into the subphase. The ﬁnal concentration of peptide in
the subphase was 4 μM. The experiments were repeated three times.
2.6. Calcein leakage experiments
A chloroformic solution of DMPC (7.5 mg) was evaporated off
under a stream of nitrogen before being dried further under
vacuum for 1 h to form a thin ﬁlm. The lipid ﬁlm was then hydrated
with 1 ml of 5.0 HEPES containing 70 mM calcein. The suspension
was vortexed for 5 min before being sonicated for 30 min The solu-
tion then underwent 5 cycles of freeze-thawing. Liposomes were
extruded 11 times through a 0.1 μm polycarbonate ﬁlter using an
Avanti Polar Lipids mini-extruder apparatus. Calcein entrapped
vesicles were separated from free calcein by gel ﬁltration using a
Sephadex G75 column (SIGMA) which was rehydrated overnight in
20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES),
150 mM NaCl and 1.0 mM ethylenediaminetetraacetic acid (EDTA).
The column was eluted with 5 mM HEPES pH 7.5.
The calcein release assay was performed by combining 2 ml 20 mM
HEPES, 150 mMNaCl and 1.0 mMEDTA (pH 7.5), 20 μl calcein vesicles.
The ﬂuorescence intensity of calcein was measured using an FP-6500
spectroﬂuorometer (JASCO, UK), with an excitation wavelength of
490 nmand an emissionwavelength of 520 nm. Tomeasuremaximum
ﬂuorescence, 20 μl of TritonX‐100was used to dissolve the vesicles. The
percentage of dye leakage was then calculated.
2.7. Molecular dynamics simulations
The mechanism of interaction between aurein 2.3 and DMPC
membrane was examined by molecular dynamics (MD) calcula-
tions for different starting positions and orientations of the peptide
with respect to the membrane as well as for different peptide con-
centrations. The aurein 2.3 model was assembled as a canonical
α-helix using AMBER tools 1.4 [31]. Simulations and analysis
were performed using GROMACS [32,33]. The GROMOS96 53a6
force ﬁeld [32,33] was used together with step descended method
DMPC. Bilayer parameters were used from the references [34,35].
The simple point-charge (SPC) water model was used in all simula-
tions. All structures were equilibrated at room temperature in
water in the sequence: minimization, NVT and NPT simulations.
The simulations in water were performed by solvating the peptide
in a box 4.48 nm×4.48 nm×4.48 nm with approximately 2900
water molecules. Counter-ions (Cl−) were added to the system to
make it neutral. The peptide was simulated with backbone atoms re-
strained in NVT and then NPT, with pressure maintained at 1 atm by
isotropic coupling to a Berendsen barostat. The temperature was
maintained at 300 K. The membrane was simulated using a DMPC
Fig. 2. RMSF of the Q (A) and H-orientation (B) for each residue in the presence of
DMPC.
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box) with the bilayer normal being parallel to the z-axis. An equilibra-
tion run was 100 ns long at 300 K in a box containing 7520 water mol-
ecules. The peptide was inserted into the box containing the solvated
bilayer. The complete peptide membrane conﬁguration has 7513
water molecules. An equilibration run of 2 ns was carried out for the
peptide-DMPC system with the position of the peptide restrained
using harmonic restrains with force constant of 1.0 kJ−1 nm−2 per
atoms [34–37]. The cut offs for both van derWaals and Coulombic inter-
actions were 1.2 nm. Berendsen temperature coupling was used at
300 K whilst the water and the bilayer were coupled separately with
coupling time of 0.1 ps for single groups. A semi-isotropic Berendsen
barostat was used with coupling time of 2.0 ps. The main molecular
dynamic simulations (no restraints) were performed at constant tem-
perature, pressure and number of molecules. In order to calculate the
angle between the lipid bilayer and the peptide the g_bundle tool
with GROMACS was used.
3. Results
3.1. Secondary structure of aurein 2.3
It has previously been shown that AMP secondary structure is
inﬂuenced by the presence of themembrane and is an important factor
in the interaction of the cationic peptide at the lipid interface [38]. In the
presence of water, the CD spectra (Fig. 1A) indicate that the peptide is
not well folded. In contrast, in the presence of DMPC and aurein 2.3
the CD spectrum consists predominantly of a maximum at 190 nm
and two minima at 210 nm and 222 nm, which is characteristic of an
α-helical structure (Fig. 1A). Further analysis, indicates that aurein 2.3
is 40.5±1.45% helical. MD simulations provide additional information
on peptide secondary structure as a function of time (Fig. 1B). For the
peptide solvated in water (no membrane present), residues 2–10 are
α-helical during the ﬁrst 30 ns and after that all traces of helicity are
lost. In the presence of DMPC, two distinct starting orientations of the
peptide with respect to the membrane are investigated: H-orientation
(peptide's hydrophobic face towards the membrane surface) and
Q-orientation (peptide's hydrophilic face towards the membrane sur-
face). For both orientations, α-helical structure is present throughout
the simulations although in the case of the H-orientation α-helical
structure occupies on average 38% of the peptide, whilst in the case of
the Q-orientation it stays around 25% (Fig. 1B).
Fig. 2 shows root-mean-square ﬂuctuations (RMSF) along the pep-
tide backbone, which provides additional information on helical sta-
bility and peptide ﬂexibility in the presence of the membrane [39].
The H-orientation exhibits larger RMSF of peptide residues comparedFig. 1. Secondary structure analysis of aurein 2.3. (A) CD spectra of aurein 2.3 in the presenc
of the aurein 2.3 in water and in the presence of DMPC for the Q-orientation and H-orientato the Q-orientation. In particular, when the peptide is started from
the Q-orientation, the peptide exhibits low ﬂexibility during the 0–
60 ns period. At this stage the peptide moves towards the lipid bilayer
without structural changes. Between 60 and 120 ns larger RMSF of
the peptide backbone are seen within the last 3 residues, indicating in-
creased peptide–membrane interaction. Between 120 and 200 ns a
small increase in RMSF of the ﬁrst 4 residues of the backbone indicates
the impact of the peptide inserting into the bilayer. In contrast, when
starting from the H-orientation the peptide residue RMSF are larger ine of water (grey) and in the presence of DMPC (black) at 30 °C. (B) Secondary structure
tion.
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(Fig. 2B). These results suggest that in the H-orientation the peptide un-
dergoes greater levels of membrane interaction.
3.2. Interaction activity of aurein 2.3 with DMPC
3.2.1. Langmuir–Blodgett and calcein leakage study
In order to characterise surface activity the behaviour of aurein 2.3
was investigated at an air–buffer interface. Fig. 3 shows that the surface
activity of aurein 2.3 depends on the peptide concentration. It can be
clearly seen that saturation is achieved at an aurein 2.3 subphase con-
centration of 4 μM. The peptide is surface active, generating a surface
pressure increase of 34 mN m−1. The ability of aurein 2.3 to penetrate
phospholipid monolayers at constant area was studied at an initial
starting surface pressure of 30 mN m−1, which is equivalent to the
lipid packing density of the outer leaﬂet of a cell membrane [39]. In
the presence of monolayers formed from zwitterionic DMPC, aurein
2.3 interaction followed hyperbolic kinetics and the peptide was
found to partition rapidly into thesemonolayers, inducingmaximal sur-
face pressure changes of 6.5 mN m−1 (Fig. 3B). These levels of interac-
tion are consistent with disruption of the monolayer acyl chain region
by aurein 2.3. In order to determine whether aurein 2.3 can
permeabilise model membranes, calcein leakage experiments were un-
dertaken using liposomes made of DMPC. It was found that aurein 2.3
induced 76% release of calcein from DMPC vesicles indicating that the
peptide had strong lytic activity.
3.2.2. Single peptide MD simulation
To investigate the activity of aurein 2.3 in the presence of a DMPC bi-
layer at the molecular level, several MD simulations were performed.
First, the peptidewas positioned at a distance of 4.5 nm from the centre
of the bilayer and oriented with its axis parallel to the bilayer sur-
face and in an arbitrary rotational orientation with respect this axis
(A-orientation, Fig. 4I). After 60 ns its inclination changed and the pep-
tide interacted with the surface of the bilayer (Fig. 4A II). The
N-terminal segment remains helical during the entire simulation and
is directly involved in the initiation of membrane penetration. The hy-
drophobic amino acids play an important role in the interaction with
the bilayer, which proceeds in a chain like fashion. First, the SER15
and LEU16 start the process of penetration followed by VAL9, VAL10
and subsequently by all the other hydrophobic amino acids in the pep-
tide. This leads to the peptide lying on the surface of the membrane.
Once the hydrophobic groups are close enough to the glycerol backbone
region, the ASP4, LYS7 and LYS8 start to be inﬂuenced by the phospho-
lipid headgroups, which results in the peptide pulled being down into
the hydrophobic core of membrane. In the ﬁnal conﬁguration the
α-carbons of the amino acids ASP4 and LYS10 are inserted into the
membrane (A-orientation, Fig. 4C). Next Q and H starting orientations
are investigated. In both cases the hydrophobic amino acids play anFig. 3. (A) Surface activity of aurein 2.3. The peptide was introduced into a subphase of a Lan
changes in surface pressure at the air/water interface monitored. (B) Shows the time course
an initial surface pressure of 30 mN m−1.important role in the interaction with the bilayer. In the case of the
Q-orientation, in the beginning the LEU2, VAL6, ILE13 and PHE3 are al-
ready located within the headgroup region (Q-orientation Fig. 4A I). A
minimal distance of 2.0 nm between the peptide and the membrane
core is observed when the head and the tail of the peptide are embed-
ded in the DMPC bilayer (Q-orientation in Fig. 4A III). In the case of
the H-orientation, LEU16 and SER15 are in close contact with themem-
brane at the beginning, whilst LYS7 and LYS8 are well outside it. During
the simulation, ILE13, LYS7, LYS8, LEU16, ASP4 and PHE3 amino acids
interact strongly with the headgroup region of DMPC. A minimal dis-
tance of 1.8 nm from the membrane core is achieved when the group
of amino acids ALA12, ILE13, GLY14, SER15 and LEU16 is in the hydro-
phobic core of themembrane and PHE3 is very close to the core of the
bilayer (Fig. 4A III). The centre of mass distance plot (Fig. 4B) shows
that a deeper penetration is observed in the case of H-orientation.
The H-orientation has a lower total energy (−3.9×105KJ mol−1)
compared to the Q-orientation (−3.8×105KJ mol−1). Fig. 4C
shows that in the H-orientation, PHE3 interacts strongly with the in-
ternal core of the membrane. PHE3 is seen to interact initially with
the headgroups and then penetrates downwards through the bilayer
(Fig. 4C). In contrast, with the Q-orientation PHE3 interacts with the
surrounding water and the outer surface of the bilayer (Fig. 4C). In ad-
dition, Fig. 5 shows that when peptide starts from the H-orientation it
penetrates deeper into the tail region of the bilayer compared with
the Q-orientation. In order to minimise the simulation time, it has
been assumed that the H and Q-orientation interact with the opposite
leaﬂet of the membrane. Moreover, the peptide is 50% more stretched
in the H-orientation compared with the Q-orientation.
To evaluate the disturbance to the membrane caused by the pep-
tide, the area per lipid within the bilayer is calculated (Fig. 6). The
area per lipid headgroup begins to decrease as interaction between
the peptide and the membrane increases. Peptide orientation was
found not to have a drastic effect on the area per lipid. The MD results
conﬁrm that as a peptide approaches the membrane the bilayer area
per lipid decreased and reached a plateau when the peptide reached
the headgroup region of the bilayer.
3.2.3. Multiple peptide MD simulation
In order to investigate a possible cooperative effect in peptide–
membrane interaction, MD simulations with two and three peptides
were conducted. Our simulations show that peptide insertion into
the bilayer depends on the peptide concentration. For two peptides,
which are adjacent to each other (not shown), peptide behaviour is
comparable to that of a single aurein 2.3. In the case of three peptides,
they exhibit a cooperative behaviour improving the probability of
penetration with a well deﬁned angle between 30° and 60°. In the ex-
periment, the peptide:lipid molar ratio was 1:2, whilst the peptide:
lipid molar ratio for the MD simulations was 3:1. It is not possible
to reach the same peptide:lipid ratio used in the experimental workgmuir-Blodgett trough to give ﬁnal concentrations ranging between 1.0 and 10 μM and
of interactions between aurein 2.3 and DMPC monolayers at constant surface area and
Fig. 4. Snapshot of the simulation for the three different starting orientations with a single peptide 4.5 nm from the surface or orientated at the surface with hydrophobic face (H) or
hydrophilic face (Q) (A), the distance between the planes containing the centre of mass of three different single peptides and the DMPC bilayer (B) showing a snapshot of the sim-
ulation in the starting position (I), 60 ns (II), and the ﬁnal conﬁguration (III). A magniﬁed snapshot of the ﬁnal conﬁguration which highlights the pore formation once the peptide
starts the penetration (C).
590 M. Mura et al. / Biochimica et Biophysica Acta 1828 (2013) 586–594
Fig. 5. Partial mass density proﬁle of the protein in presence of DMPC (the lipid head
and tail groups in black) and water (red). The peptides in H (blue) and Q-orientation
(violet) and the density of the phenylalanine density (pink and green) are shown.
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vide an insight into the nature of the interaction of aurein 2.3 with
the membrane. Fig. 7A shows that at the start of the simulation, the
three aurein peptides (denoted as A, B and C) are set parallel to the
membrane surface and each other at a distance of 4.5 nm from the bi-
layer (position I). However, after 15 ns the peptides form a conglom-
erate trying to minimise their hydrophobic surface. As the simulation
continues, the two aurein peptides, peptide A and peptide B, push
peptide C towards the lipid bilayer enabling the PHE3 residue to in-
teract with the lipid headgroup of the bilayer. Fig. 7A position II,
shows the PHE3 of peptide C opening the way towards the centre of
the bilayer. At the end of the simulation (position III, Fig. 7A) a full in-
sertion of peptide C into the hydrophobic region of the bilayer is ob-
served with the other two peptides at the membrane surface. The
cooperative interaction between the three peptides manifests itself
in the correlated behaviour of distance plots in Fig. 7B which closely
follow each other after 15 ns. The ﬁnal conﬁguration shown in
Fig. 7C highlights these cooperative effects with the PHE3 residue of
peptide C being buried in the bilayer. MSD calculations show thatFig. 6. Area per lipid as a function of time for the H-orientation (in black) and
Q-orientation (in red) of the peptide.the MSD plateaued at 0.8 nm2 at 200 ns (similar to the case of single
peptide), indicating that there is a small effect on the area per lipid
value (not shown).
3.3. Orientation of aurein 2.3
Langmuir monolayers are used to investigate the ability of peptides
to orientate at the air–buffer interface using pressure/area isotherms.
When aurein 2.3 is spread at the air/buffer interface, the peptide formed
stable monolayers. Fig. 8A shows the pressure/area isotherm of aurein
2.3monolayers, where a collapse point is observed at a surface pressure
of 33.5 mN m−1 and amolecular area of 1.73 nm2. Fig. 8A also gives the
ﬁrst indication of the molecular area of the peptide at the interface.
Here, the extrapolated area/molecule of 3.1 nm2 (0.19 nm2 per amino
acid residue) and an area at lift-off of 4.5 nm2 (0.28 nm2 per amino
acid residue) are in agreement with the peptide adopting an α-helix
conformation at an asymmetric interface [40]. The data also indicate
that the peptide preferentially orientates perpendicular to the surface
[40], which is similar to the orientation found for other amphiphilic
peptides such as aurein 2.5 [41]. According to these data the peptide's
elasticity ranged from 12.5 to 50 mN m−1 (Table 1) and indicates
that the monolayer was in the liquid expanded phase state [42], as ob-
served for other aurein peptides [43].
MD simulations show that a single aurein 2.3 orientates at an angle
of between 35° and 45° to the membrane upon insertion (Fig. 8B).
Fig. 8C shows the angles formed by peptides A, B and C to the surface
plane of the bilayer when the 3 peptides are modelled. Up to 150 ns,
each aurein axis shows similar behaviour. However, between 150 ns
and 400 ns peptide C orientates at 40°whilst peptides A and B orientate
at around 30°, which corresponds to the point of deepest penetration
for the peptide C and supports the auxiliary role of peptides A and B.
4. Discussion
Despite intensive research into α-AMP function [1–7,10,21–24],
very little is known about the detailed molecular interactions be-
tween the peptide and the lipid bilayer, which eventually lead to
membrane permeabilisation. Experimental data combined with MD
is an approach that is able to make a signiﬁcant contribution to un-
derstanding the mechanisms of action of AMPs. AMPs have been
shown to display a wide range of structural conformations in solution
ranging from partial α-helical, β-sheet to random coil. MD and CD
(Fig. 1) structural studies showed that aurein 2.3 were unstructured
in solution and then folds to form helical structure in the presence
of a DMPC lipid environment. For many AMPs, regardless of the
mechanism of membrane interaction, an asymmetric interface has
been shown to be a requirement for the transition to an α-helical
conformation. Simulations of the solution structure show that the
N-terminus is likely to act as the nucleus for amphiphilic α-helical
formation and indeed Fig. 4 conﬁrms that the N-terminus forms a sta-
ble helix with the leucine residues driving membrane penetration
(Fig. 2) and leading to hydrophobic partitioning. This would support
the large pressure changes observed with DMPC monolayers (Fig. 3)
and is aligned with the CD studies showing 41% helical structure in
the presence of a DMPC interface (Fig. 1A).
Aurein 1.2 has been previously modelled and computational
studies showed that the orientation of a C-terminal PHE residue
was critical for efﬁcient antibacterial action [25]. Aurein 2.3 pos-
sesses an N-terminal phenylalanine residue at position 3, which
we show to penetrate into the bilayer as a precursor to pore forma-
tion (Fig. 4C). Lensink et al., [44] experimentally demonstrated that
the starting orientation of the peptide at the interface can affect the
ﬁnal binding and orientation of the peptide. Our MD results conﬁrm
that in the H-orientation, the PHE3 in aurein 2.3 enables stabilisation
of the peptide at the interface and supports the adoption of a tilted
orientation similar to other oblique orientated AMPs such as the
Fig. 7. Snapshot of the simulation for the three different starting orientations of the three peptide system during the simulation (A), the centre of mass difference of three different
single peptides and the DMPC bilayer (B) showing a snapshot of the simulation in the starting position (I), after 60 ns (II), and the ﬁnal conﬁguration (III). A magniﬁed snapshot of
the ﬁnal conﬁguration, which highlights the pore formation (C).
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several other AMPs using MD and has been conﬁrmed in the case of
aurein 1.2 [24,46,47], which adopts an oblique orientation at high
peptide-to-lipid ratios. It is thought that membrane lysis is induced by
the adoption of these oblique structures [10,11,15] due to the
destabilisation of lipid packing [16,17]. In support of this suggestion,
Fig. 8C and Fig. 8D show that there is a greater tilt on the peptide as it
inserts into the membrane and shows that this leads to changes in
membrane thickness. Experimental data has shown that other amphib-
ian AMPs insert into the membrane using oblique orientation at a shal-
low angle between 30° and 60°, resulting in membrane destabilisation
[10] and Fig. 4 shows aurein 2.3 inserts into a bilayer at an angle of
43°. At a critical peptide concentration, this may lead to the classicalmodel of interaction such as the toroidal pore. In the present study,
Fig. 7C clearly shows that multiple aurein 2.3 molecules form the start
of a pore which would then lead to membrane destabilisation. This is
supported by calcein release assays indicating that aurein 2.3 caused
signiﬁcant lysis of DMPC vesicles (76%). Cooperative effects have previ-
ously been reported to stabilise hydrophobic and hydrophilic compo-
nents within the peptide–lipid system [48,49] and here we show that
such effects could also drive membrane disruption.
In the case of aurein 2.3, lysine residues LYS7 and LYS8 form strong
interactions with the lipid headgroup region whilst enabling the resi-
due α-carbons to snorkel deeper into the membrane hydrophobic
core (Fig. 4). This snorkelling effect would be expected to lead to
changes in structural ﬂexibility observed in the simulation (Fig. 2 and
Fig. 8. The orientation of aurein 2.3. (A) Shows a pressure–area isotherm for a aurein
2.3 monolayer, which was spread from chloroform on to a subphase of 10 mM Tris,
pH 7.5. (B) Proﬁle of the behaviour of the angle between the long axis of a single pep-
tide and the bilayer surface. (C) Proﬁle of the behaviour of angle between the long axis
of each single peptide and the bilayer surface when 3 peptides are present.
Table 1
Surface compression modulus (Cs−1) for aurein 2.3.
Surface pressure (mN m−1) Cs−1 (mN m−1)
5 8.57
10 38.61
15 49.50
20 60.30
25 62.85
593M. Mura et al. / Biochimica et Biophysica Acta 1828 (2013) 586–594Fig. 4). This orientation of the peptide at the membrane interface leads
to headgroups being pushed aside by the LYS7 and LYS8 peptide, there-
by forcing a gap in the hydrophobic region leading to hydrophobic pos-
itive mismatch, which in turn leads to the breakdown of themembrane
[19]. In positive mismatch, the hydrophobic thickness exceeds the
membrane lipids and hence the peptide may tilt. Cheng et al., [25]
showed that electrostatic interaction and bilayer thickness played animportant role in peptide–lipid interaction. In support of this sugges-
tion, during the time of simulation, the thickness of the bilayer in-
creased when the peptide was orientated with the hydrophobic face
towards the bilayer surface (data not shown).
5. Conclusion
In summary, themechanism of action of aurein 2.3 has been studied
using a series of biophysical techniques and MD simulations. The data
suggests that the mechanism of membrane interaction involves the
peptide adopting an oblique membrane interactive α-helix with inter-
action being initiated from the peptide's N-terminus. Interaction with
the membrane shows evidence of snorkelling and hydrophobic
mismatch driving membrane disruption with LYS7 and LYS8 pushing
the helix into the hydrophobic core of the bilayer and PHE3 having a
key role in creating the precursor to the pore. The presence of multiple
molecules is seen to have a cooperative effect, increasing the depth of
peptide penetration into the bilayer and consequently increasing the ef-
ﬁcacy of the system.
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